Athyrium Capital Management, LP 13F Holdings

CIK 0001728001 · NEW YORK, NY

As of Sep 30, 2024, Athyrium Capital Management, LP reported 2 positions worth $8.7M in its SEC Form 13F filing.

Top 2 holdings

SecurityTickerSectorSharesValue% of portfolio
BIORA THERAPEUTICS INC——10,929,762$5.5M63.12%
PUMA BIOTECHNOLOGY INCPBYIHealthcare1,256,411$3.2M36.88%